- Projects
- Campylobacter
- Production Status
- Campylobacter concisus 13826
- Campylobacter curvus 525.92
- Campylobacter fetus subsp. fetus 82-40
- Campylobacter hominis ATCC BAA-381
- Campylobacter jejuni subsp. doylei 269.97
- Campylobacter jejuni subsp. jejuni 260.94
- Campylobacter jejuni subsp. jejuni 81-176
- Campylobacter jejuni subsp. jejuni 84-25
- Campylobacter jejuni subsp. jejuni CF93-6
- Campylobacter jejuni subsp. jejuni HB93-13
Campylobacter Genome Project
This project is complete. Please see the production status page for links to public data.
Goals
The genomes of five well-characterized Campylobacter jejuni subsp. jejuni strains will be sequenced to 8-fold coverage and the genomes of four emerging infectious isolates of Campylobacter and the only known commensal of Campylobacter will be completed. This work will significantly expand and complement the Campylobacter comparative genome project that was completed in 2005. The strains we have chosen for sequencing possess significant genetic differences that influence their pathogenic potential or constitute a non-pathogenic reference for in silico genomic subtraction. The variety of diseases caused and virulence capabilities of these strains underscores the diversity within the species. It is anticipated that this wealth of information will help address fundamental questions about the genomic basis of Guillain-Barre syndrome (GBS) and Miller-Fisher syndrome (MFS), of pathogenesis of atypical/extraintestinal and emerging C. jejuni strains, of the diversity of Campylobacter spp. (and virulence mechanisms) causing human illness, and to determine the extent of gene transfer among Campylobacter spp., resulting in the emergence of non-C. jejuni subsp. jejuni infectious agents. Furthermore, this data will aid in forensic analysis in cases of bioterrorism by facilitating the generation of detection systems and supply targets for vaccine development.
Isolates
Strain selection was preformed after consultation with the Campylobacter scientific community resulting in the selection of ten Campylobacter strains that are targeted for genomic sequencing. Analysis of the genomic data will allow for examination of genetic differences, including gross chromosomal changes and individual polymorphisms, and their correlation to disease progression and outcomes caused by this important biodefense agent.
Investigators and Collaborators
Blaser, Dr. Martin J., M.D. | New York University School of Medicine, USA |
DiRita, Victor J., Ph.D. | University of Michigan Medical School, USA |
Dingle, Kate, Ph.D. | University of Oxford John Radcliffe Hospital, UK |
Endtz, Hubert P., M.D. | Erasmus University Medical Center, The Netherlands |
Fouts, Derrick E. | J. Craig Venter Institute |
Gilbert, Michel, Ph.D. | National Research Council of Canada |
Godschalk, Peggy C. R. | University Medical Center, Rotterdam, The Netherlands |
Guerry, Patricia, Ph.D. | Naval Medical Research Center, USA |
Lastovica, Albert J., Ph.D. | University of Cape Town, South Africa |
Mandrell, Robert E., Ph.D. | USDA Western Regional Research Center, USA |
Miller, William G., Ph.D. | USDA Western Regional Research Center, USA |
Mongodin, Emmanuel | Institute for Genome Sciences, University of Maryland School of Medicine |
Nachamkin, Irving, Dr.P.H., M.P.H. | University of Pennsylvania Health System, USA |
Nelson, Karen E. | J. Craig Venter Institute |
On, Stephen L. W., Ph.D. | Danish Institute for Food and Veterinary Research, Denmark |
Szymanski, Christine, Ph.D. | National Research Council of Canada |
Ussery, Dave, Ph.D. | Technical University of Denmark |
Wassenaar, Trudy M., Ph.D. | Molecular Microbiology & Genomics Consultants, Germany |
Wren, Brendan W., Ph.D. | London School of Hygiene & Tropical Medicine, UK |
Yuki, Nobuhiro, Ph.D. | Dokkyo University School of Medicine, Japan |